E744G (p.Glu744Gly) variant of MFN2 (Mitofusin-2)
E744G (p.Glu744Gly) in MFN2 (Mitofusin-2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as conflicting interpretations in the context of Charcot-Marie-Tooth disease type 2; not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.81 / 1. The record also includes published literature and structural context.
E744G (p.Glu744Gly) variant details
- p.Glu744Gly
- rs1131691782
- ClinGen CA338454350
- ClinVar RCV000492878
- ClinVar RCV001856973
- Conflicting interpretations
- Charcot-Marie-Tooth disease type 2; not provided
- Missense
- Variant Prioritization Score for Impact Estimate 0.805
- AlphaMissense 0.93
- MetaLR 0.92
- MetaSVM 1.03
- PolyPhen-2 0.99
- SIFT 0.00
- EVE 0.40
- ClinVar: Conflicting classifications of pathogenicity (Charcot-Marie-Tooth disease type 2; not provided)
- EBI: Likely pathogenic (in CMT2A2A)
- UniProt: Likely pathogenic (in CMT2A2A)
- Structural context available
- Cited in: Charcot-Marie-Tooth Hereditary Neuropathy Overview. (PMID 20301532)